From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease

被引:15
|
作者
Mortellaro, Alessandra [1 ]
Ricciardi-Castagnoli, Paola [1 ]
机构
[1] Singapore Immunol Network SIgN, Agcy Sci Technol & Res A STAR, Biopolis, Singapore
来源
IMMUNOLOGY AND CELL BIOLOGY | 2011年 / 89卷 / 03期
关键词
vaccination; immune protection; infections; adjuvants; T-CELL RESPONSES; PNEUMOCOCCAL CONJUGATE VACCINE; MYCOBACTERIUM-BOVIS BCG; MONOPHOSPHORYL-LIPID-A; DENDRITIC CELLS; HEPATITIS-B; ALUMINUM-HYDROXIDE; ANTIBODY-RESPONSES; INFLUENZA VACCINATION; MALARIA VACCINE;
D O I
10.1038/icb.2010.152
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the past 50 years, the practice of vaccination has reached the important goal of reducing many of the diseases that afflicted humanity in past centuries. A better understanding of immunological mechanisms underlying the induction of immune protection and the advent of new technology led to improved vaccine preparations based on purified microbial antigens and new adjuvants able to boost both humoral and cellular immune responses. Despite these tremendous advances, much remains to be done. The emergence of new pathogens, the spread of strains resistant to antibiotics and the enormous increase in latent infections are urgently demanding more and more effective vaccines. Understanding the immunological mechanisms that mediate resistance against infections would certainly provide valuable information for the design of new candidate vaccines. Immunology and Cell Biology (2011) 89, 332-339; doi:10.1038/icb.2010.152; published online 8 February 2011
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [1] Contribution of advances in immunology to vaccine development
    Morrison, WI
    Taylor, G
    Gaddum, RM
    Ellis, SA
    [J]. ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 181 - 195
  • [3] Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK
    Fitchett, Joseph R.
    Head, Michael G.
    Atun, Rifat
    [J]. VACCINE, 2013, 31 (50) : 5930 - 5933
  • [4] IMMUNOLOGY OF HUMAN TUBERCULOSIS - PERSPECTIVES FOR VACCINE DEVELOPMENT
    ELLNER, JJ
    [J]. CHEST, 1989, 95 (03) : S237 - S240
  • [5] Vaccine adjuvants for infectious disease in the clinic
    Goetz, Morgan
    Thotathil, Naaz
    Zhao, Zongmin
    Mitragotri, Samir
    [J]. BIOENGINEERING & TRANSLATIONAL MEDICINE, 2024, 9 (04)
  • [6] Infectious disease: Typhoid vaccine effective
    Hutchinson E.
    [J]. Nature Reviews Gastroenterology & Hepatology, 2009, 6 (10) : 563 - 563
  • [7] Advances in Infectious Disease Vaccine Adjuvants
    Fan, Jingyi
    Jin, Shengbin
    Gilmartin, Lachlan
    Toth, Istvan
    Hussein, Waleed M.
    Stephenson, Rachel J.
    [J]. VACCINES, 2022, 10 (07)
  • [8] INFECTIOUS DISEASE The race for a Zika vaccine is on
    Cohen, Jon
    [J]. SCIENCE, 2016, 351 (6273) : 543 - 544
  • [9] The prevention of Lyme disease with vaccine
    Poland, GA
    Jacobson, RM
    [J]. VACCINE, 2001, 19 (17-19) : 2303 - 2308
  • [10] Knowledge, attitude and practice on human papillomavirus vaccine for prevention of cervical cancer
    Myat, S. H.
    Myat, T. T.
    Nyunt, K. K.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 155 - 155